Literature DB >> 8543945

Gosha-jinki-gan (herbal medicine) in streptozocin-induced diabetic neuropathy.

M Nishizawa1, W H Sutherland, H Nukada.   

Abstract

Long-established systems of traditional medicine have evolved from systematic recordings of human experience over several millennia. Although not strictly based on concepts of modern science, they nevertheless are founded on a corpus of organised knowledge written in documents, and the evident conclusion is that the alleged "trial and error" methodology has provided useful drugs for humans. Herbal medicine should be investigated as a potential regimen for diabetic neuropathy for the following reasons: (1) diabetic neuropathy remains an important clinical problem affecting a significant proportion of diabetic subjects without satisfactory treatment; (2) there are multiple pathogenetic mechanisms in diabetic neuropathy; and (3) herbal medicine which is a combination prescription has unique synergistic and synthetic effects that result from interactions between individual herbal components, and may induce a wide range of therapeutic potential and utility. Gosha-jinki-gan (GJK), consisting of 10 herbs, has been widely used for a regimen of diabetic complications, including neuropathy, in Japan. However, the effect of GJK on experimental diabetic neuropathy has never been previously evaluated. We examined nerve conduction velocity (NCV) and nerve glucose, sorbitol, fructose and myo-inositol levels in streptozocin (STZ)-induced diabetic rats that were treated with GJK. After 1 week of the STZ injection in 7-9-week-old rats, GJK treatment (100 mg/100 g body weight/day) was started orally. At 16 weeks after the STZ injection, the sciatic NCV of GJK-treated diabetic rats improved significantly when compared to non-treated diabetic rats, although they were not yet normalised.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543945     DOI: 10.1016/0022-510x(95)00141-n

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats.

Authors:  Zeng Zhang; Hong-Li Xue; Yi Liu; Wen-Jian Wang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

2.  Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.

Authors:  Eiji Oki; Yasunori Emi; Hiroshi Kojima; Jun Higashijima; Takeshi Kato; Yasuhiro Miyake; Masanori Kon; Yutaka Ogata; Kenichi Takahashi; Hideyuki Ishida; Hiroshi Saeki; Yoshihisa Sakaguchi; Takeharu Yamanaka; Toru Kono; Naohiro Tomita; Hideo Baba; Ken Shirabe; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2015-01-28       Impact factor: 3.402

3.  Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.

Authors:  Nobuaki Hoshino; Riki Ganeko; Koya Hida; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2017-12-21       Impact factor: 3.402

4.  Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.

Authors:  Nobuaki Hoshino; Koya Hida; Riki Ganeko; Yoshiharu Sakai
Journal:  Int J Colorectal Dis       Date:  2016-11-26       Impact factor: 2.571

5.  A clinical trial of kampo formulae for the treatment of symptoms of yusho, a poisoning caused by dioxins and related organochlorine compounds.

Authors:  Hiroshi Uchi; Shoji Tokunaga; Chikage Mitoma; Satoko Shibata; Naoki Hamada; Yoichi Nakanishi; Junboku Kajiwara; Takesumi Yoshimura; Masutaka Furue
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-09       Impact factor: 2.629

6.  Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling.

Authors:  Bolin Qin; Masaru Nagasaki; Ming Ren; Gustavo Bajotto; Yoshiharu Oshida; Yuzo Sato
Journal:  Evid Based Complement Alternat Med       Date:  2004-07-21       Impact factor: 2.629

7.  The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action.

Authors:  Yukiko Matsumura; Yoshihito Yokoyama; Hachidai Hirakawa; Tatsuhiko Shigeto; Masayuki Futagami; Hideki Mizunuma
Journal:  Mol Pain       Date:  2014-09-21       Impact factor: 3.395

8.  Hypoglycemic Effect of Laminaria japonica Polysaccharide in a Type 2 Diabetes Mellitus Mouse Model.

Authors:  Xiaodan Li; Zhuqin Yu; Shaohua Long; Yunliang Guo; Delin Duan
Journal:  ISRN Endocrinol       Date:  2012-10-30

9.  Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients.

Authors:  Jun-Ichi Yamakawa; Yoshiharu Motoo; Junji Moriya; Masao Ogawa; Hiroaki Uenishi; Sumiyo Akazawa; Toshiyuki Sasagawa; Matomo Nishio; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-19       Impact factor: 2.629

10.  Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.

Authors:  Toshihisa Onoda; Wei Li; Koji Higai; Kazuo Koike
Journal:  BMC Complement Altern Med       Date:  2014-02-20       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.